ArticleESMO open2022
Erratum to 'Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario': [ESMO Open Volume 7, Issue 2, April 2022, 100406].
Abstract readPublished Erratum
In one paragraph
Article in ESMO open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
62 authors.
L CantiniDepartment of Medical Oncology, Università Politecnica delle Marche, AOU Ospedali Riuniti di Ancona, Ancona, Italy.
G MentrastiDepartment of Medical Oncology, Università Politecnica delle Marche, AOU Ospedali Riuniti di Ancona, Ancona, Italy.
G Lo RussoOncologia Medica 1, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
D SignorelliNiguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
G PaselloDepartment of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy; Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padua, Italy.
E RijavecMedical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
M RussanoDepartment of Medical Oncology, Campus Bio-Medico University, Rome, Italy.
L AntonuzzoMedical Oncology Unit, Careggi University Hospital, Florence, Italy.
D RoccoDepartment of Pulmonology and Oncology, AORN dei Colli Monaldi, Naples, Italy.
R GiustiUOC Oncologia Medica, Azienda Ospedaliero Universitaria Sant'Andrea, Università La Sapienza, Rome, Italy.
V AdamoOncologia Medica, A.O.Papardo & Università di Messina, Messina, Italy.
C GenovaUOC Clinica di Oncologia Medica, IRCCS Ospedale San Martino, Genoa, Italy; Department of Internal Medicine and Medical Specialties (DIMI), Università degli Studi di Genova, Genoa, Italy.
A TuziOncologia Medica, ASST Sette Laghi, Varese, Italy.
A MorabitoThoracic Medical Oncology, Istituto Nazionale Tumori "Fondazione G Pascale", IRCCS, Naples, Italy.
S GoriUOC Oncologia Medica, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar di Valpolicella, Verona, Italy.
N La VerdeDepartment of Oncology, Ospedale Luigi Sacco, ASST Fatebenefratelli Sacco, Milan, Italy.
R ChiariMedical Oncology, Ospedali Riuniti Padova Sud, Monselice, Italy.
A CortelliniMedical Oncology, St Salvatore Hospital, L'Aquila, Italy.
V CognigniDepartment of Medical Oncology, Università Politecnica delle Marche, AOU Ospedali Riuniti di Ancona, Ancona, Italy.
F PecciDepartment of Medical Oncology, Università Politecnica delle Marche, AOU Ospedali Riuniti di Ancona, Ancona, Italy.
A IndiniMedical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
A De TomaOncologia Medica 1, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
E ZattarinOncologia Medica 1, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
S OrestiNiguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.
E G PizzutiloNiguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.
S FregaMedical Oncology 2, Istituto Oncologico Veneto IRCCS, Padua, Italy.
E ErbettaMedical Oncology 2, Istituto Oncologico Veneto IRCCS, Padua, Italy.
A GallettiDepartment of Medical Oncology, Campus Bio-Medico University, Rome, Italy.
F CitarellaDepartment of Medical Oncology, Campus Bio-Medico University, Rome, Italy.
S FancelliMedical Oncology Unit, Careggi University Hospital, Florence, Italy.
E CalimanMedical Oncology Unit, Careggi University Hospital, Florence, Italy.
L Della GravaraDipartment of Experimental Medicine, Università degli Studi della Campania "Luigi Vanvitelli", Naples, Italy.
U MalapelleDepartment of Public Health, Università degli Studi di Napoli "Federico II", Naples, Italy.
M FilettiUOC Oncologia Medica, Azienda Ospedaliero Universitaria Sant'Andrea, Università La Sapienza, Rome, Italy.
M PirasUOC Oncologia Medica, Azienda Ospedaliero Universitaria Sant'Andrea, Università La Sapienza, Rome, Italy.
G ToscanoOncologia Medica, A.O.Papardo, Messina, Italy.
L ZulloUOC Oncologia Medica 2, IRCCS Ospedale San Martino, Genoa, Italy.
M De TursiDepartment of Innovative Technologies in Medicine & Dentistry, Università G. D'Annunzio, Chieti-Pescara, Chieti, Italy.
P Di MarinoDepartment of Innovative Technologies in Medicine & Dentistry, Università G. D'Annunzio, Chieti-Pescara, Chieti, Italy.
V D'EmilioUOC Pneumologia, Ospedale Mazzoni, Ascoli Piceno, Italy.
M S ConaDepartment of Oncology, Ospedale Luigi Sacco, ASST Fatebenefratelli Sacco, Milan, Italy.
A GuidaOncologia Medica e Traslazionale, AO Santa Maria, Terni, Italy.
A CaglioDepartment of Oncology, University of Turin, Ordine Mauriziano Hospital, Turin, Italy.
F SalernoDepartment of Oncology, University of Turin, Ordine Mauriziano Hospital, Turin, Italy.
G P SpinelliUOC Territorial Oncology, University "Sapienza", AUSL Latina, Cds Aprilia, Aprilia, Italy.
C BennatiDepartment of Onco-Hematology, AUSL della Romagna, Ravenna, Italy.
F MorgilloUOC Oncologia ed Ematologia, Department of Precision Medicine, Università degli studi della Campania "Luigi Vanvitelli", Naples, Italy.
A RussoOncologia Medica, A.O.Papardo, Messina, Italy.
C DellepianeUOC Oncologia Medica 2, IRCCS Ospedale San Martino, Genoa, Italy.
I ValliniOncologia Medica, ASST Sette Laghi, Varese, Italy.
V SforzaThoracic Medical Oncology, Istituto Nazionale Tumori "Fondazione G Pascale", IRCCS, Naples, Italy.
A InnoUOC Oncologia Medica, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar di Valpolicella, Verona, Italy.
F RastelliUOC Oncologia, Ospedale Mazzoni, Ascoli Piceno, Italy.
V TassiChirurgia Toracica, AO Santa Maria, Terni, Italy.
L NicolardiMedical Oncology, Ospedali Riuniti Padova Sud, Monselice, Italy.
M V PensieriMedical Oncology, St Salvatore Hospital, L'Aquila, Italy.
R EmiliOperative Oncology Unit, Ospedale Santa Maria della Misericordia, Urbino, Italy.
E RocaThoracic Oncology - Lung Unit, Pederzoli Hospital, Peschiera Del Garda, Italy.
A MiglioreDepartment of Medical Oncology, Università Politecnica delle Marche, AOU Ospedali Riuniti di Ancona, Ancona, Italy.
T GalassiDepartment of Medical Oncology, Università Politecnica delle Marche, AOU Ospedali Riuniti di Ancona, Ancona, Italy.
M B L RocchiBiomolecular Sciences Department, University of Urbino, Urbino, Italy.
R BerardiDepartment of Medical Oncology, Università Politecnica delle Marche, AOU Ospedali Riuniti di Ancona, Ancona, Italy. Electronic address: r.berardi@staff.univpm.it.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.